PL205228B1 - Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD - Google Patents
Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHDInfo
- Publication number
- PL205228B1 PL205228B1 PL376121A PL37612105A PL205228B1 PL 205228 B1 PL205228 B1 PL 205228B1 PL 376121 A PL376121 A PL 376121A PL 37612105 A PL37612105 A PL 37612105A PL 205228 B1 PL205228 B1 PL 205228B1
- Authority
- PL
- Poland
- Prior art keywords
- virus
- rhd
- rabbit
- rhdv
- serum
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 94
- 241001465754 Metazoa Species 0.000 title claims abstract description 25
- 210000002966 serum Anatomy 0.000 title claims description 42
- 238000001514 detection method Methods 0.000 title claims description 12
- 239000000427 antigen Substances 0.000 claims abstract description 50
- 108091007433 antigens Proteins 0.000 claims abstract description 50
- 102000036639 antigens Human genes 0.000 claims abstract description 50
- 241000714203 Rabbit hemorrhagic disease virus Species 0.000 claims abstract description 49
- 238000012360 testing method Methods 0.000 claims abstract description 44
- 238000002965 ELISA Methods 0.000 claims abstract description 28
- 238000009007 Diagnostic Kit Methods 0.000 claims abstract description 25
- 230000003053 immunization Effects 0.000 claims abstract description 20
- 238000002649 immunization Methods 0.000 claims abstract description 13
- 238000010171 animal model Methods 0.000 claims abstract description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 80
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 201000010099 disease Diseases 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 108010045075 rabbit hemorrhagic disease virus viral protein 60 Proteins 0.000 claims description 18
- 241000700199 Cavia porcellus Species 0.000 claims description 17
- 241000701447 unidentified baculovirus Species 0.000 claims description 17
- 101710172711 Structural protein Proteins 0.000 claims description 15
- 230000002008 hemorrhagic effect Effects 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 13
- 230000035931 haemagglutination Effects 0.000 claims description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 210000000234 capsid Anatomy 0.000 claims description 10
- 229960005486 vaccine Drugs 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 241000238631 Hexapoda Species 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 7
- 230000003067 hemagglutinative effect Effects 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 238000005199 ultracentrifugation Methods 0.000 claims description 6
- 238000002255 vaccination Methods 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 230000005764 inhibitory process Effects 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 230000000405 serological effect Effects 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 4
- 239000006143 cell culture medium Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000013641 positive control Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000001492 haemagglutinating effect Effects 0.000 claims description 3
- 210000004201 immune sera Anatomy 0.000 claims description 3
- 229940042743 immune sera Drugs 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 208000005647 Mumps Diseases 0.000 claims description 2
- 241000256251 Spodoptera frugiperda Species 0.000 claims description 2
- 238000002835 absorbance Methods 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 230000002458 infectious effect Effects 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 208000010805 mumps infectious disease Diseases 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000002594 sorbent Substances 0.000 claims description 2
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims 1
- RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000000203 mixture Substances 0.000 description 10
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 9
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 108090000565 Capsid Proteins Proteins 0.000 description 5
- 102100023321 Ceruloplasmin Human genes 0.000 description 5
- 108010076039 Polyproteins Proteins 0.000 description 5
- 230000000890 antigenic effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 241001466949 European brown hare syndrome virus Species 0.000 description 4
- 241000723784 Plum pox virus Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000825469 Haemulon vittatum Species 0.000 description 3
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 3
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 3
- 102100024407 Jouberin Human genes 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 108091027544 Subgenomic mRNA Proteins 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000714198 Caliciviridae Species 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000009589 serological test Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 1
- 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 1
- 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101800001383 Capsid protein VP60 Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 1
- 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 1
- 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 241000714201 Feline calicivirus Species 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000714213 San Miguel sea lion virus Species 0.000 description 1
- 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 1
- 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 1
- 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 1
- 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241001494970 Vesicular exanthema of swine virus Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 1
- 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 1
- 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229940023860 canarypox virus HIV vaccine Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 238000011309 routine diagnosis Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108091069025 single-strand RNA Proteins 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL376121A PL205228B1 (pl) | 2005-07-08 | 2005-07-08 | Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD |
| EP06769510A EP1904850A2 (de) | 2005-07-08 | 2006-07-06 | Diagnostischer kit zur untersuchung von tierseren auf das vorhandensein von anti-rhd-antikörpern und diagnostischer kit zum nachweis des rhd-virus |
| PCT/PL2006/000046 WO2007008092A2 (en) | 2005-07-08 | 2006-07-06 | Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL376121A PL205228B1 (pl) | 2005-07-08 | 2005-07-08 | Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL376121A1 PL376121A1 (pl) | 2007-01-22 |
| PL205228B1 true PL205228B1 (pl) | 2010-03-31 |
Family
ID=37401477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376121A PL205228B1 (pl) | 2005-07-08 | 2005-07-08 | Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1904850A2 (de) |
| PL (1) | PL205228B1 (de) |
| WO (1) | WO2007008092A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102250234B (zh) * | 2011-06-13 | 2013-04-17 | 中国农业科学院哈尔滨兽医研究所 | 一种与兔出血症病毒vp60蛋白相结合的蛋白及其应用 |
| CN105486861B (zh) * | 2015-07-02 | 2017-07-11 | 山东省滨州畜牧兽医研究院 | 一种兔瘟病毒抗体快速检测卡及其制备方法 |
| CN105277696A (zh) * | 2015-10-26 | 2016-01-27 | 中国农业科学院上海兽医研究所 | 兔出血症病毒双抗夹心elisa检测试剂盒及使用方法 |
| CN106802349A (zh) * | 2016-12-30 | 2017-06-06 | 广东华南联合疫苗开发院有限公司 | Sf昆虫细胞宿主细胞蛋白双抗夹心酶联免疫检测试剂盒及方法 |
| CN109856397B (zh) * | 2018-12-26 | 2022-06-21 | 山东绿都生物科技有限公司 | 一种快速检测兔瘟病毒的胶体金检测卡及其制备方法 |
| CN113252891A (zh) * | 2021-01-08 | 2021-08-13 | 中国农业科学院兰州兽医研究所 | 检测塞尼卡病毒a抗体的试剂盒 |
| CN112881710B (zh) * | 2021-02-04 | 2022-04-22 | 中国农业科学院兰州兽医研究所 | 一种用于检测口蹄疫病毒抗体的抑制elisa方法及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2080023B1 (es) * | 1994-07-08 | 1996-08-16 | Iberica Cyanamid | Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes. |
-
2005
- 2005-07-08 PL PL376121A patent/PL205228B1/pl unknown
-
2006
- 2006-07-06 EP EP06769510A patent/EP1904850A2/de not_active Ceased
- 2006-07-06 WO PCT/PL2006/000046 patent/WO2007008092A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1904850A2 (de) | 2008-04-02 |
| WO2007008092A2 (en) | 2007-01-18 |
| PL376121A1 (pl) | 2007-01-22 |
| WO2007008092A3 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8114408B2 (en) | Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof | |
| JP4813471B2 (ja) | ハンタウイルス感染の診断のための方法および試薬 | |
| JP2014138593A (ja) | Ｅ型肝炎ウイルスのポリペプチド断片、それを含むワクチン組成物及び診断キット、並びにその使用 | |
| WO2009150429A2 (en) | Vaccine | |
| CN117043177A (zh) | 非洲猪瘟diva免疫测定 | |
| EP0518756B1 (de) | Verfahren zum Nachweis einer Rinderdiarrhoe- virusinfektion, für ein durch eine Infektion mit diesem Virus induziertes Eiweiss kodierende Nukleotidsequenz, sowie daraus abgeleitete rekombinante Eiweisse und Antigene | |
| Yarbough | Hepatitis E virus: advances in HEV biology and HEV vaccine approaches | |
| AU2009256397A1 (en) | Expression and assembly of human group C rotavirus-like particles and uses thereof | |
| Jiang et al. | Expression and characterization of Sapporo-like human calicivirus capsid proteins in baculovirus | |
| PL205228B1 (pl) | Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD | |
| Lavazza et al. | How many caliciviruses are there in rabbits? A review on RHDV and correlated viruses | |
| US10041132B2 (en) | Pestivirus species | |
| Samal et al. | Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells | |
| Zhang et al. | Prophylactic hepatitis E vaccine | |
| DeSheng et al. | Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV | |
| RU2843305C1 (ru) | Иммуноферментная тест-система для оценки антигенной и иммуногенной активности противоящурной вакцины на основе штамма "SAT-2/XIV/2023" вируса ящура | |
| Lugovskaya et al. | Development and application of ELISA test system for assessing humoral immunity against SAT2 topotype XIV foot-and-mouth disease virus | |
| PL205229B1 (pl) | Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki | |
| Metwally et al. | Study on a New Isolate of Rabbit Haemorrhagic Disease Virus | |
| CN118647391A (zh) | 抗原性多肽及其用途 | |
| Lavazza et al. | 3.7. Rabbit haemorrhagic disease (RHD) | |
| HK40116654A (zh) | 抗原性多肽及其用途 | |
| Yarbough et al. | Hepatitis E virus: biology, pathogenesis, epidemiology, clinical description, diagnosis, and prevention | |
| HK1071436B (en) | Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars) | |
| HK1071436A1 (en) | Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (sars) |